Single-day praziquantel versus 1-week albendazole for neurocysticercosis
- 1 March 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 52 (5) , 1079
- https://doi.org/10.1212/wnl.52.5.1079
Abstract
Article abstract The efficacy of albendazole (15 mg/kg/d for 1 week) was compared with praziquantel (100 mg/kg in three divided doses at 2-hour intervals) for therapy of parenchymal brain cysticercosis. Ten patients were treated with albendazole and 10 patients with praziquantel. Although the total number of cysts was significantly reduced from 64 to 7 in patients treated with albendazole and from 59 to 24 in those treated with praziquantel, the number of patients improving with albendazole was not significantly different from those treated with praziquantel.Keywords
This publication has 8 references indexed in Scilit:
- Albendazole therapy for neurocysticercosisNeurology, 1997
- Single-Day Praziquantel Therapy for NeurocysticercosisNew England Journal of Medicine, 1996
- Medical Treatment of Cysticercosis--EffectiveArchives of Neurology, 1995
- Therapy for NeurocysticercosisArchives of Neurology, 1992
- Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluationTransactions of the Royal Society of Tropical Medicine and Hygiene, 1991
- Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosisZeitschrift für Neurologie, 1990
- High-Dose Praziquantel for Neurocysticercosis: Efficacy and TolerabilityEuropean Neurology, 1990
- Therapy of Parenchymal Brain Cysticercosis with PraziquantelNew England Journal of Medicine, 1984